Ultragenyx Pharmaceutical Inc. Share Price
NASDAQ: RAREHealthcare
Live Ultragenyx Pharmaceutical Inc. Share Price Chart
O H L
Ultragenyx Pharmaceutical Inc. Performance Overview
Days Range
▼
$14.07Low
$14.69High
Markets Today
| Previous Close | $14.50 |
|---|---|
| Open | $14.69 |
| Volume | 2,020,193 |
| Day's Range | $14.07 - $14.69 |
| 52W Range | $12.73 - $39.89 |
| Market Cap | $1.27 B |
Historical Performance
| 1M Returns | -43.11 |
|---|---|
| 3M Returns | -47.16 |
| 6M Returns | -29.13 |
| 1Y Returns | -50.19 |
| 5Y Returns | -85.24 |
| 10Y Returns | -81.07 |
Ultragenyx Pharmaceutical Inc. Fundamentals
| Market Cap | $1.27 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $673.00 M |
| ROE TTM | -6.56 |
| EPS TTM | $-5.84 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-500.00 M |
| Profit Margin | -85.44 |
| Market Cap | $1.27 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $673.00 M |
| ROE TTM | -6.56 |
| EPS TTM | $-5.84 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-500.00 M |
| Profit Margin | -85.44 |
Ultragenyx Pharmaceutical Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $139.00 M | $167.00 M | $159.93 M | $207.28 M | $136.00 M | $214.00 M |
| Gross Profit + | $110.00 M | $144.00 M | $131.94 M | $177.93 M | $106.00 M | $180.00 M |
| Operating Income | -$143.00 M | -$108.00 M | -$170.89 M | -$113.28 M | -$169.00 M | -$75.00 M |
| EBITDA | -$134.00 M | -$99.00 M | -$162.28 M | -$104.50 M | -$161.00 M | -$67.00 M |
| Interest Expense | -$14.00 M | -$14.00 M | -$14.15 M | -$19.47 M | -$21.00 M | -$22.00 M |
| Depreciation | $9.00 M | $9.00 M | $8.61 M | $8.79 M | $8.00 M | $8.00 M |
| Income Before Tax | -$150.00 M | -$114.00 M | -$179.54 M | -$127.69 M | -$184.00 M | -$91.00 M |
| Income Tax Expense | $1.00 M | $1.00 M | $873.00 K | $870.00 K | $1.00 M | $1.00 M |
| Net Income + | -$151.00 M | -$115.00 M | -$180.41 M | -$128.56 M | -$185.00 M | -$92.00 M |
| Net Profit Margin | -108.63% | -68.86% | -112.81% | -62.02% | -136.03% | -42.99% |
Ultragenyx Pharmaceutical Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $94.00 K | $96.00 K | $96.00 K | $0 | $0 | $0 |
| Reserve & Surplus | -$4.11 B | -$4.22 B | -$4.40 B | -$4.53 B | -$4.72 B | -$4.81 B |
| Non-Current Liabilities | $869.01 M | $854.74 M | $834.26 M | $1.22 B | $1.20 B | $1.20 B |
| Current Liabilities | $291.67 M | $293.24 M | $340.02 M | $384.00 M | $325.00 M | $351.00 M |
| Total Liabilities | $1.16 B | $1.15 B | $1.17 B | $1.60 B | $1.52 B | $1.55 B |
| Fixed Assets | $437.43 M | $430.50 M | $422.90 M | $420.00 M | $413.00 M | $407.00 M |
| Current Assets | $699.15 M | $719.79 M | $643.21 M | $951.00 M | $657.00 M | $606.00 M |
| Total Assets | $1.31 B | $1.31 B | $1.19 B | $1.53 B | $1.30 B | $1.26 B |
Ultragenyx Pharmaceutical Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$151.00 M | -$115.00 M | -$180.41 M | -$128.56 M | -$185.00 M | -$92.00 M |
| Operating Cash Flow | -$166.00 M | -$109.00 M | -$91.42 M | -$99.83 M | -$197.00 M | -$97.00 M |
| Investing Cash Flow | $120.00 M | $71.00 M | $117.18 M | -$72.25 M | -$49.00 M | $44.00 M |
| Financing Cash Flow | $0 | $84.00 M | $2.00 K | $394.19 M | $0 | $3.00 M |
| Change in Cash | -$45.00 M | $50.00 M | $26.05 M | $221.46 M | -$247.00 M | -$49.00 M |
Ultragenyx Pharmaceutical Inc. Return Calculator
The Ultragenyx Pharmaceutical Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,463
Invested Amount$10,000
Est. Returns$-8,537
About Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.
Popular Stocks
FAQs
What is the share price of Ultragenyx Pharmaceutical Inc. today?
Ultragenyx Pharmaceutical Inc. (RARE) share price as of September 18, 2026 is $14.38. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Ultragenyx Pharmaceutical Inc.?
Yes, Indian Investors can invest in the Ultragenyx Pharmaceutical Inc. (RARE) Share by opening an international trading account with Angel One.
How can I purchase Ultragenyx Pharmaceutical Inc. shares in India?
Purchasing Ultragenyx Pharmaceutical Inc. (RARE) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Ultragenyx Pharmaceutical Inc. (RARE) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Ultragenyx Pharmaceutical Inc.?
Yes, you can purchase fractional shares of Ultragenyx Pharmaceutical Inc. (RARE) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Ultragenyx Pharmaceutical Inc.?
The market capitalization of Ultragenyx Pharmaceutical Inc. on September 18, 2026, is $1.27 B.
In which sector Ultragenyx Pharmaceutical Inc. belongs?
Ultragenyx Pharmaceutical Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Ultragenyx Pharmaceutical Inc. stocks?
In order to invest in Ultragenyx Pharmaceutical Inc. (RARE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
